trending Market Intelligence /marketintelligence/en/news-insights/trending/QWSn7QI_6oCQV8HfIId7tQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Novartis names CEO of oncology unit; Ionis CEO to move to chairman role

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Novartis names CEO of oncology unit; Ionis CEO to move to chairman role

S&P Global Market Intelligence presents a weekly rundown of recent executive changes at pharmaceutical, biotech and life sciences companies.

* Novartis AG said Susanne Schaffert, president of its unit Advanced Accelerator Applications S.A., will become CEO of Novartis Oncology, effective Jan. 1. Schaffert will replace Liz Barrett, who will step down as CEO of the oncology unit, effective Dec. 31.

* Ionis Pharmaceuticals Inc. said founder and CEO Stanley Crooke will transition to executive chairman of the company's board of directors, effective January 2020. Brett Monia, who has been COO for the previous year and a founding member of Ionis, will take over from Crooke as CEO.

* CytoDyn Inc. appointed Nitya Ray as the company's chief technology officer — head of process sciences, manufacturing and supply chain.

* Phosphagenics Ltd said Anna Legg stepped down as the company's secretary and CFO. The company appointed Melanie Leydin as replacement secretary and CFO, effective Dec. 28., while Michael Sapountzis was also named joint company secretary.

* Phylogica Ltd. said Robert Hayes stepped down as the company's chief scientific officer.

* Editas Medicine Inc. said Andrew Hack is resigning as the company's CFO, effective March 1, 2019.

* Veritas Pharma Inc. said David Alexander resigned as the company's CFO. Peter McFadden will replace Alexander on an interim basis.

* Akorn Inc. appointed Douglas Boothe as the company's president and CEO, effective Jan. 1, 2019.

* Amicus Therapeutics Inc. named its senior vice president Daphne Quimi CFO, effective Jan. 1, 2019.